Development and testing of a random forest-based machine learning model for predicting events among breast cancer patients with a poor response to neoadjuvant chemotherapyYudi Jin, Shengchun Liu, Ailin Lan et al.|European journal of medical research|2023Cited by 73
Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patientsYihua Wang, Shengchun Liu, Yu Wang et al.|BMC Cancer|2021Cited by 16
A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinomaHaochen Yu, Shengchun Liu, Yong Fu et al.|Aging|2022Cited by 15
Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast CancerYingkun Xu, Shengchun Liu, Yinan Wu et al.|Journal of Oncology|2022Cited by 14
Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective studyLingfeng Tang, Shengchun Liu, Zhenghang Li et al.|Frontiers in Oncology|2022Cited by 10